4//SEC Filing
Gentry Leesa 4
Accession 0001641172-25-017831
CIK 0001574094other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:45 PM ET
Size
6.3 KB
Accession
0001641172-25-017831
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Gentry Leesa
Chief Clinical Officer
Transactions
- Award
Stock Option
2025-07-01+6,619→ 6,619 totalExercise: $1.27→ Common Stock (6,619 underlying)
Footnotes (2)
- [F1]Represents an award of 2,621 incentive stock options and 3,998 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the "Plan") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025.
- [F2]The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035.
Documents
Issuer
RenovoRx, Inc.
CIK 0001574094
Entity typeother
Related Parties
1- filerCIK 0002013097
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:45 PM ET
- Size
- 6.3 KB